The global assisted reproductive technology (ART) market reached USD 23.54 billion in 2024 and is projected to grow at a CAGR of 6.50%, reaching USD 44.19 billion by 2034. The growth is primarily driven by the rising prevalence of infertility, increasing maternal age, and advancements in reproductive technologies. Expanding awareness of fertility treatments, improved success rates of ART procedures, and supportive government policies in various regions further contribute to market expansion.

The increasing adoption of in-vitro fertilization (IVF), artificial insemination, and embryo preservation techniques is boosting demand, alongside growing investment in fertility clinics and research facilities.

Market Segmentation

By Type:

In-Vitro Fertilization (IVF):

• Fresh Donor

• Frozen Donor

• Fresh Non-Donor

• Frozen Non-Donor

Artificial Insemination:

• Intrauterine Insemination (IUI)

• Intracervical Insemination

• Intravaginal Insemination

• Intratubal Insemination

By Product:

Instruments

Accessory & Disposable

Reagent & Media

By Age Group:

Women Younger Than 35

Women Older Than 35

By Application:

Frozen Embryo Replacement (FER)

Surrogacy

Ovulation Induction

Others

By End User:

Fertility Clinics & Other Facilities

Hospitals & Others

By Region:

North America (U.S., Canada)

Europe (U.K., Germany, France, Italy, Spain)

Asia Pacific (Japan, China, India, Australia, South Korea)

Latin America (Mexico, Brazil, Argentina)

Middle East & Africa (South Africa, Saudi Arabia, UAE)

Leading Companies in the ART Market

Major players driving innovation and adoption include:

• Microm U.K. Ltd.

• CooperSurgical, Inc.

• FUJIFILM Irvine Scientific

• Cyprus IVF Centre

• Vita Altera IVF Center

• Cryolab Ltd.

• Vitrolife AB

• European Sperm Bank

• Bloom IVF Centre

• Merck KGaA

These companies focus on developing advanced fertility instruments, culture media, and consumables, alongside improving IVF success rates and patient outcomes.

Get a Free Sample Report with Table of Contents - www.expertmarketresearch.com/reports/assisted-reproductive-technology-market/requestsample

Trends and Opportunities Shaping the ART Market

Rising Maternal Age: Delayed pregnancies increase demand for ART services.

Technological Advancements: Innovations in embryo freezing, genetic screening, and minimally invasive procedures enhance success rates.

Growing Fertility Clinics: Expansion of fertility centers in emerging markets supports accessibility.

Increasing Awareness: Public campaigns and patient education boost ART adoption.

Surrogacy and FER: Expanding use of frozen embryo replacement and surrogacy programs drives market growth.

The assisted reproductive technology market is poised for steady growth through 2034, driven by innovative treatment options, supportive infrastructure, and increasing consumer demand, making ART a critical component of global reproductive healthcare.